Unlock the Power of Real-World Data
Harness the power of real-world data to inform your critical decisions, drive innovation, and enhance patient outcomes.
Discover Cytel’s Extensive Real-World Data Sources
Real-world data (RWD), sourced from diverse healthcare settings, provides unique insights into treatment outcomes beyond clinical trials. Cytel offers you access to a vast array of RWD sources, allowing you to leverage advanced analytical methods to expedite study initiation, accelerate market entry, and ensure treatment safety. Combining unparalleled clinically rich health data with human expertise, we enable timely decision-making while protecting patient privacy. We harness RWD to help you navigate the complexities of drug development, and inform regulatory decisions, healthcare policy, and patient care. Ultimately we empower you to optimize therapeutic outcomes and transform your clinical practice.
Contact usDiverse data sources
Gain access to a wide range of healthcare datasets, giving you insights across various therapeutic areas and populations.
Advanced analytics
Employ cutting-edge analytical techniques to extract meaningful insights from Real-World Data to drive evidence-based decision-making.
Expedited study initiation
Leverage RWD to accelerate the start of clinical studies, reducing time-to-market for new therapies.
Enhanced safety monitoring
Employ RWD to strengthen your post-market surveillance, ensuring the ongoing safety and efficacy of treatments in real-world settings.
Real-World Data Sources
Cytel has access to more than 75 global RWD sources allowing for comprehensive insights into patient populations and treatment outcomes, including:
- Healthcare insurance claims data
- Electronic medical record (EMR) data
- Drug prescription and pharmacy data
- Hospital data networks
- Oncology databases
- Clinical outcome assessments
With access to these rich datasets, Cytel supports you in evidence-driven decision-making to accelerate clinical research across therapeutic areas. Our robust RWD sources empower your team to uncover valuable insights and drive innovations in healthcare delivery and patient outcomes.
Fit-for-Purpose Data Tool™
Could you benefit from streamlined data sourcing and enhanced decision-making? Cytel’s Fit-for-Purpose Data Tool™ addresses the challenge of disparate data sources in real-world evidence studies. It streamlines data selection, saving time and resources, and ensuring data quality. The wizard matches data sources efficiently, qualifies them based on fit-for-purpose parameters, and quantifies trade-offs. This transparency enables informed decision-making and simplifies data licensing. The wizard allows you to package longitudinal patient data sets to meet regulatory mandates and present them to payers. It ranks available data sets according to user-input criteria, facilitating optimal data selection for study parameters.
Learn More
Our comprehensive Real-World Data solutions
Our solutions empower you to harness the full potential of RWD for evidence generation, whether you’re accelerating study timelines or exploring new research questions.
- Data landscape analysis: Accelerate and optimize data utility through extensive analysis of available data sources within our network.
- Feasibility & quality validation: Assess data source feasibility and content quality to align with your study objectives with our Fit-for-Purpose Data Wizard™.
- Data strategy: Our experts evaluate your company’s goals and challenges to craft a tailored data strategy supporting regulatory and commercial evidence generation.
- Registry development: Plan and establish data registries with multi-geographical coverage.
Maximize Comparative Effectiveness with External Controls
Take full advantage of the potential of RWD in comparative effectiveness studies by leveraging Cytel’s expertise in external control arms (ECA). With a proven track record in regulatory submissions and strategic advice, we can support you with tailored solutions for ECA design and implementation. Our dedicated team conducts comprehensive data landscaping studies, ensuring the selection of high-quality data sources, and providing strategic support to develop fit-for-purpose RWD strategies. From identifying global data sources to performing feasibility assessments, we guide you through every step of the process, enabling you to make informed decisions and optimize the use of RWD in your comparative effectiveness studies.
Learn More>75
Cytel’s access to unique global RWD sources
>200
Team of RWE, HEOR and Regulatory specialists
>1B
Access to 1B+ patient records
>7,000
Access to oncology network of 7000+ physicians
Claim your free 30-minute strategy session
Book a free, no-obligation strategy session with our team of strategic consultants to get advice on how to improve your drug's probability of success.
